Show simple item record

dc.contributor.authorMartin, Erin
dc.contributor.authorSadowski, Catherine
dc.date.accessioned2021-04-06T20:17:01Z
dc.date.available2021-04-06T20:17:01Z
dc.date.issued2021
dc.identifier.urihttp://hdl.handle.net/10898/12588
dc.description.abstractCrohn's Disease (CD) is an incurable type of inflammatory bowel disease (IBD), in which the intestines are chronically inflamed, causing intestinal and extra-intestinal symptoms. CD patients experience a cycle of remission and relapse of symptoms as the disease progresses to serious complications, including small bowel obstructions, malnutrition, and decreased quality of life. Since CD is incurable, medical management is the mainstay of treatment to obtain and maintain remission. Traditional treatment relies on anti-inflammatories. New management strategies focuses on early and aggressive therapy with immunomodulators and biologics to reduce the rate of mucosal and intestinal damage early in the disease course.
dc.subjectCollege of Health Professions
dc.subjectARC21--Night 3
dc.titleManagement of Crohn's Disease: Early and Aggressive Treatment Using Biologics and Immunomodulators
dc.typePresentation
refterms.dateFOA2021-04-06T20:17:01Z


Files in this item

Thumbnail
Name:
ARC21_COHP_026.pdf
Size:
2.732Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record